Intrahepatic Cholangiocarcinoma  >>  capecitabine  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
capecitabine / Generic mfg.
NCT00003867: Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Completed
1
30
US
capecitabine, irinotecan hydrochloride
Montefiore Medical Center, National Cancer Institute (NCI)
Cancer
03/03
03/03
NCT00010023: Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Completed
1
US
capecitabine, cisplatin
NYU Langone Health, National Cancer Institute (NCI)
Cancer
08/07
 
NCT00486356: Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Completed
1
46
US
capecitabine, Xeloda, carboplatin, Paraplatin, epirubicin hydrochloride, Ellence, microarray analysis, polymorphism analysis, pharmacological study
University of Nebraska, National Cancer Institute (NCI)
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Liver Cancer, Unspecified Adult Solid Tumor, Protocol Specific
01/10
01/10

Download Options